TT Electronics, a provider of engineered electronics for healthcare, aerospace, defence, electrification, and automation applications, reported that the U.S. FDA has confirmed registration for its Cleveland, OH manufacturing facility. As an FDA-registered establishment, the facility can perform manufacturing of finished medical instruments and devices, like imaging and diagnostic systems.
The registration follows TT’s earlier announcement of its new, advanced manufacturing facility in Asia, which allows the company to further broaden its capabilities supporting life science customers.
“This is an important step in our healthcare industry growth strategy. Our FDA designation will provide a significant advantage in supporting our current customers, many of whom are global leaders in their fields,” said TT Electronics EVP Michael Leahan in a news release. “TT has been supporting medical and life science technology innovators for over a decade. Our customers can now leverage our expanded capabilities in the USA to manufacture and deliver finished, complex medical products – with the same world class service experience that they’ve come to expect from TT.”
TT has design and manufacturing facilities in the UK, North America, Sweden, and Asia.